Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Cognito reaps $105M in series C funding for its Alzheimer’s device

Cognito reaps $105M in series C funding for its Alzheimer’s device

  • March 6, 2026

Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round.

Leave A Comment

Fields (*) Mark are Required